These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32538874)

  • 21. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States.
    Lobb WB; Wilkin NE; Holmes ER
    Int J Pharm Compd; 2015; 19(6):514-20. PubMed ID: 26891565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability in compounding of oral liquids for pediatric patients: a patient safety concern.
    Rood JM; Engels MJ; Ciarkowski SL; Wagenknecht LD; Dickinson CJ; Stevenson JG
    J Am Pharm Assoc (2003); 2014; 54(4):383-9. PubMed ID: 25063260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescription of compounded ophthalmic medications-a pharmacy perspective.
    Weekes L; Ramzan I
    Clin Exp Optom; 2021 Apr; 104(3):406-411. PubMed ID: 32253769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.
    AlKhatib HS; Jalouqa S; Maraqa N; Ratka A; Elayeh E; Al Muhaissen S
    BMC Health Serv Res; 2019 Nov; 19(1):816. PubMed ID: 31703672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hospital Compounding in Nigeria: A Review of Needs, Practice, and Suggestions for Pharmaceutical Dispensing Ciurriculum Development.
    Orubu ESF; Patani BO; Arhewoh MI
    Int J Pharm Compd; 2021; 25(6):475-481. PubMed ID: 34807842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compounding vs standardized commercial parenteral nutrition product: pros and cons.
    Gervasio J
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):40S-41S. PubMed ID: 22301324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk and liabilities of prescribing compounded medications.
    Randell MD; Duffy PJ
    Postgrad Med; 2014 Jul; 126(4):178-80. PubMed ID: 25276868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and content validation of an assessment tool for medicine compounding on hospital wards.
    Suvikas-Peltonen E; Granfors E; Celikkayalar E; Laaksonen R; Palmgren J; Airaksinen M
    Int J Clin Pharm; 2016 Dec; 38(6):1457-1463. PubMed ID: 27817169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specialty compounding for improved patient care: 2006 national survey of compounding pharmacists.
    Huffman DC; Holmes ER
    Int J Pharm Compd; 2008; 12(1):74-82. PubMed ID: 23969574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors.
    Watson CJ; Whitledge JD; Siani AM; Burns MM
    J Med Toxicol; 2021 Apr; 17(2):197-217. PubMed ID: 33140232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a standardized Intranet database of formulation records for nonsterile compounding, Part 2.
    Haile M; Anderson K; Evans A; Crawford A
    Int J Pharm Compd; 2012; 16(2):104-9. PubMed ID: 23050321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compounding for animal patients: contemporary issues.
    Lust E
    J Am Pharm Assoc (2003); 2004; 44(3):375-84; quiz 384-6. PubMed ID: 15191248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential clinical impact of compounded versus noncompounded intrathecal baclofen.
    Moberg-Wolff E
    Arch Phys Med Rehabil; 2009 Nov; 90(11):1815-20. PubMed ID: 19887203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Access to age-appropriate essential medicines: a retrospective survey of compounding of medicines for children in hospitals in Nigeria and implications for policy development.
    Orubu ES; Okwelogu C; Opanuga O; Nunn T; Tuleu C
    Health Policy Plan; 2017 Mar; 32(2):225-235. PubMed ID: 28207051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aseptic preparation of parenteral medicinal products in healthcare establishments in Europe.
    Scheepers H; Beaney AM; Le Brun P; Neerup Handlos V; Schutjens M; Walser S; Neef C
    Eur J Hosp Pharm; 2016 Jan; 23(1):50-53. PubMed ID: 31156814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration errors of compounded semaglutide reported to a poison control center-Case series.
    Lambson JE; Flegal SC; Johnson AR
    J Am Pharm Assoc (2003); 2023; 63(5):1643-1645. PubMed ID: 37392810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.